| International Organising Committee |
| Symposium Chairmen |
| B. CLEMENT (Kiel University, Kiel, Germany) |
| E. OTTOW (Bayer HealthCare, Berlin, Germany) |
| Members |
| K. AUGUSTYNS (University of Antwerp, Antwerp, Belgium) |
| R. P. CLAUSEN (University of Copenhagen) |
| E. DIFFERDING (Differding Consulting, Louvain-la-Neuve, Belgium) |
| R. MOREIRA (University of Lisbon, Lisbon, Portugal) |
| H. TIMMERMAN (VU University Amsterdam, Amsterdam, The Netherlands) |
| Local Organising Committee |
| Members |
| K.-H. ALTMANN (ETH Zurich, Zurich, Switzerland) |
| A. BUSCHAUER (University of Regensburg, Regensburg, Germany) |
| P. GMEINER (Friedrich Alexander University, Erlangen, Germany) |
| R. HAAG (Free University Berlin, Berlin, Germany) |
| M. KALESSE (University of Hannover, Hannover, Germany) |
| S. LAUFER (University of Tuebingen, Tübingen, Germany) |
| J. MACK (Boehringer Ingelheim, Biberach an der Riss, Germany) |
| H. P. MAERKI (F. Hoffmann-La Roche, Basel, Switzerland) |
| P. H. SEEBERGER (Max Planck Institute of Colloids and Interfaces, Berlin, Germany) |
| O. SEITZ (Humboldt University Berlin, Berlin, Germany) |
| H. U. STILZ (Sanofi-Aventis, Malov, Denmark) |
| R. D. SÜSSMUTH (Technical University Berlin, Berlin, Germany) |
| H. WALDMANN (Max Planck Institute of Molecular Physiology, Dortmund, Germany) |
| H. WEINMANN (Bayer Pharma, Berlin, Germany) |
| International Scientific Committee |
| Members |
| M. D. ANDREWS (Pfizer, Sandwich, United Kingdom) |
| P. ARTURSON (University of Uppsala, Uppsala, Sweden) |
| S. O. BACHURIN (Institute of Physiologically Active Compounds, Chernogolovka, Russia) |
| E. BANOGLU (Gazi University, Ankara, Turkey) |
| M. BRANDS (Bayer AG, Wuppertal, Germany) |
| T. CARELL (Ludwig-Maximilians-University Munich, Munich, Germany) |
| N. CARRUTHERS (Johnson & Johnson R&D, San Diego, United States) |
| G. CRISTALLI (University of Camerino, Camerino, Italy) |
| F. DA SETTIMO (Università di Pisa, Pisa, Italy) |
| P. S. DA SILVA (Bial Ltd, S. Mamede do Coronado, Portugal) |
| A. M. DAVIS (AstraZeneca R&D, Loughborough, United Kingdom) |
| F. DENONNE (UCB Pharma, Braine-l'Alleud, Belgium) |
| G. DUBURS (Latvian Institute of Organic synthesis, Riga, Latvia) |
| G. ECKER (University of Vienna, Vienna, Austria) |
| P. ETTMAYER (Boehringer Ingelheim, Vienna, Austria) |
| J. FISCHER (Richter Plc, Budapest, Hungary) |
| C. GARCIA-ECHEVERRIA (Sanofi, Vitry sur Seine, France) |
| M. GASIC (Serbian Academy of Sciences and Art, Belgrade, Serbia and Montenegro) |
| G. GAVIRAGHI (Siena Biotech, Siena, Italy) |
| E. GILLAM (University Queensland, Brisbane, Australia) |
| M. HANN (GSK Medicines Research Centre, Stevenage, United Kingdom) |
| R. HARTMANN (Saarland University, Saarbruecken, Germany) |
| L. HENNEQUIN (AstraZeneca, Reims, France) |
| T. HOFFMANN (F. Hoffmann-La Roche, Basel, Switzerland) |
| U. HOLZGRABE (University of Wuerzburg, Wuerzburg, Germany) |
| K. KIEC-KONONOWICZ (Jagiellonian University, Krakow, Poland) |
| G. KLEBE (Philipps-University Marburg, Marburg, Germany) |
| A. KOUROUNAKIS (University of Athens, Athens, Greece) |
| J. LAU (Novo Nordisk, Maaloev, Denmark) |
| B. LESUR (Institut de Recherches Servier, Croissy-Sur-Seine, France) |
| R. LEURS (VU University Amsterdam, Amsterdam, The Netherlands) |
| M. L. LOPEZ-RODRIGUEZ (Complutense University of Madrid, Madrid, Spain) |
| D. MA (Shanghai Institute of Organic Chemistry, Shanghai, China) |
| I. MALNAR (Galapagos, Zagreb, Croatia) |
| R. MECHOULAM (Hebrew University, Jerusalem, Israel) |
| L. MEERPOEL (Janssen R&D, Beerse, Belgium) |
| R. METTERNICH (F. Hoffmann-La Roche, Basel, Switzerland) |
| J. MINERS (Flinders University School of Medicine, Bedford Park, Australia) |
| M. MISSBACH (Novartis, Basel, Switzerland) |
| C. MÜLLER (University of Bonn, Bonn, Germany) |
| K. MÜLLER (F. Hoffmann-La Roche, Basel, Switzerland) |
| P. O'NEILL (University of Liverpool, Liverpool, United Kingdom) |
| D. OLIVER (North-West University, Potchefstroom, South Africa) |
| R. PELLICCIARI (University of Perugia & EFMC, Perugia, Italy) |
| L. PETERLIN MASIC (University of Ljubljana, Ljubljana, Slovenia) |
| D. ROGNAN (University of Strasbourg, Illkirch, France) |
| Y. ROLLAND (Société de Chimie Thérapeutique, Châtenay-Malabry, France) |
| M. ROWLEY (Merck Research Laboratories, Kriens, Switzerland) |
| F. SANZ (University Pompeu Fabra, Barcelona, Spain) |
| G. SCHNEIDER (ETH Zürich, Zurich, Switzerland) |
| G. SERRA (Udelar, Montevideo, Uruguay) |
| K. B. SIMONSEN (Lundbeck, Valby, Denmark) |
| G. TAMAGNAN (Institute for Neurodegenerative Disorders and Molecular NeuroImaging, LLC, New Haven, United States) |
| B. K. TRIVEDI (Wockhardt R&D, Aurangabad, India) |
| J. UETRECHT (University of Toronto, Toronto, Canada) |
| E. WALLEN (University of Helsinki, Helsinki, Finland) |
| H. WEINSTEIN (Cornell University, New York, United States) |
| R. WEXLER (DuPont Merck Pharmaceutical Co., Princeton, United States) |
| J. WÖLFLING (University of Szeged, Szeged, Hungary) |
| A. YONATH (Weizmann Institute of Science, Rehovot, Israel) |
| L.-H. ZHANG (Beying Medical University, Beying, China) |
| M.-Q. ZHANG (Amgen China, Shanghai, China) |
